Search results
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 hours agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 1 day agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 day agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech reports net loss of €315.1m in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 11 hours agoBioNTech has experienced a significant shift in its financial standing, reporting a net loss of €315.1m ($339.3m) in the first quarter (Q1) of 2024. This...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 day agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 1 day agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 1 day ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
Analyst Report: BioNTech SE
Morningstar Research via Yahoo Finance· 1 day agoBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious ...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 5 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 1 day agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
